Cstone pharmaceuticals co. ltd
WebApr 4, 2024 · -- CStone Pharmaceuticals zegt dat de resultaten van zijn registrerende klinische studie naar sugemalimab voor de behandeling van lymfeklierkanker zijn gepubliceerd in het Journal of Clinical... 10 april 2024 WebCStone Pharmaceuticals Co. Ltd. 's Exposure is Medium. Low. Medium. High. Management. Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies. CStone Pharmaceuticals Co. Ltd. 's Management of ESG …
Cstone pharmaceuticals co. ltd
Did you know?
WebFor the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making. Unlike other intelligence solutions, BCIQ exclusively supports the … WebCStone Pharmaceuticals is a biopharma company focused on developing and commercializing innovative immuno-oncology and molecularly targeted drugs to address … TIBSOVO ® is an oral targeted IDH1 inhibitor. The NMPA of China has … Suzhou, China, March 20th, 2024--CStone Pharmaceuticals (HKEX: 2616), a … Compared to western countries, China is a late starter in clinical development, and … Your privacy is important for us. We use cookies to enhance your experience … CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on … Medical Information Consultant Joy Type：Medical Information Consultant … CStone Suzhou Translational Medicine Research Center (TMRC) is a cutting … Sugemalimab is an investigational anti-PD-L1 monoclonal antibody discovered by … Address: 21/F, No. 399, West Haiyang Road, New Bund Times Square, …
WebFeb 24, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, … WebApr 6, 2024 · CStone Pharmaceuticals is a China-based investment holding company. Through its subsidiaries, the Company is primarily engaged in development, …
WebView CStone Pharmaceuticals Co Ltd's company headquarters address along with its other key offices and locations. Head Office. CStone Pharmaceuticals Co Ltd Country. China. Address. 21/F, No. 399, West Haiyang Road, New Bund Times Square, Pudong New Area, Shanghai, Shanghai, 200072. Phone Number. 86 021 60335000 ... WebNov 24, 2024 · CStone Pharmaceuticals Co Ltd’s Ipilimumab Biosimilar Drug Details: Ipilimumab biosimilar (CS-1002) is under development for the treatment of solid tumors including colorectal cancer, hepatocellular carcinoma, malignant pleural mesothelioma, pancreatic adenocarcinoma, prostate cancer, gastro-intestinal stromal tumor, …
WebJiangsu Hengrui Pharmaceuticals Co., Ltd. 21,357 followers on LinkedIn. Promote a healthier life for humankind through advancements in science Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a global pharmaceutical company engaged in the development and commercialization of innovative and high-quality drugs, focusing on the …
WebJun 7, 2024 · Cstone Pharmaceuticals Co. Ltd.’s orally administered Tibsovo (ivosidenib tablets) received the green light from China’s NMPA for use in adult patients with relapsed/refractory acute myeloid leukemia (r/r AML) with a susceptible isocitrate dehydrogenase 1 (IDH1) mutation. It is the first IDH1 inhibitor to reach market in China. my holidays check inWebThe following section provides information on CStone Pharmaceuticals Co Ltd’s senior management, executives, CEO and key decision makers and their roles in the … my holidays etcWebDec 30, 2024 · CStone Pharmaceuticals Co Ltd 2616 CS-3002 Oncology Solid Tumor Company Reports 01 Dec 2024 Phase I Trial Initiation CStone Pharmaceuticals Co Ltd 2616 ipilimumab biosimilar Oncology Solid Tumor ... ohiopyle kentuck campground